ALLR
Allarity Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Allarity Therapeutics (ALLR) Stock: Buy, Sell, or Hold?
$0.94
+0.03 (+2.76%)
▲
5d:
-13.4%
30d:
+7.52%
90d:
-31.23%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 13, 2026
TODAY
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
48/100
Position
FAIR
30-Day Fair Range
$0.86 – $1.00
Position: FAIR
Forward P/E & Valuation
-1.1x
Next 12M consensus est.
Wall Street Target
$11.00
+1076.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.85 / $1.18
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: ALLR is down 13.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When ALLR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ALLR is currently trading at $0.94, which is considered fair relative to its 30-day fair value range of $0.86 to $1.00.
Technical Outlook: Technically, ALLR is in a strong downtrend. Immediate support is located at $0.85, while resistance sits at $1.18.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $11.00 (+1076.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALLR is in a strong downtrend. Immediate support is located at $0.85, while resistance sits at $1.18.
Market Sentiment: The stock scores a mixed 41/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $11.00 (+1076.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.86 -
$1.00
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
Trading Range & Key Levels
30-Day Trading Range
$0.86 -
$1.00
Current vs Trading Range
FAIR
Support Level
$0.85
Resistance Level
$1.18
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (41/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1076.1% below Wall St target ($11.00)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.09
Wall Street Target
$11.00
(+1076.1%)
Share ALLR Analysis
Share this live ALLR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ALLR)
Bullish
2 Retail Mentions
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits shows 100.0% bullish sentiment towards $ALLR with no recent news articles available.
Key Retail Themes:
Bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 7:18 PM ET
Data refreshes hourly during market hours. Next update: 8:18 PM
Data refreshes hourly during market hours. Next update: 8:18 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALLR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 35 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 62 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ALLR Research Pages
